In parallel, PON1 activity in HDL3 was significantly decreased in all CAD patients (SA, 30%, p = 0.005; ACS, 50%, p = 0.0003) compared to N subjects (Fig. 3e). The gene discussed is PON1; the disease is coronary artery disorder.